Net profit of Sai Life Sciences rose 86.41% to Rs 100.38 crore in the quarter ended December 2025 as against Rs 53.85 crore during the previous quarter ended December 2024. Sales rose 26.53% to Rs 556.46 crore in the quarter ended December 2025 as against Rs 439.78 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales556.46439.78 27 OPM %33.7627.23 - PBDT186.53105.74 76 PBT142.4671.65 99 NP100.3853.85 86 Powered by Capital Market - Live News

Sai Life Sciences will hold a meeting of the Board of Directors of the Company on 5 February 2026.Powered by Capital Market - Live News

Sai Life Sciences has allotted 8,89,133 equity shares under ESOP on 19 December 2025. Powered by Capital Market - Live News

Net profit of Sai Life Sciences rose 101.98% to Rs 83.84 crore in the quarter ended September 2025 as against Rs 41.51 crore during the previous quarter ended September 2024. Sales rose 35.88% to Rs 537.47 crore in the quarter ended September 2025 as against Rs 395.56 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales537.47395.56 36 OPM %27.1325.84 - PBDT151.8091.24 66 PBT112.0555.32 103 NP83.8441.51 102 Powered by Capital Market - Live News

Sai Life Sciences will hold a meeting of the Board of Directors of the Company on 6 November 2025.Powered by Capital Market - Live News